MicroPort Scientific : First Surgery of Using Takin™ Spinal Posterior Fixation System ...

Nanchang, China - On August 5, Professor Rongli Yang of Peking University People's Hospital and Professor Qi Liao and Director Zhiping Zhang of the Third Affiliated Hospital of Nanchang University successfully completed a surgery using MicroPort Orthopedics' Takin™ Spinal Posterior Fixation System in the treatment of complex spinal tumor.

The female patient was diagnosed with S2 space occupying lesion. The surgeons performed removal of S2 space occupying lesion and spine internal fixation with Takin™ Spinal Posterior Fixation System. The surgery lasted for one hour and achieved successful outcome with little blood loss. Professor Rongli Yang, Professor Qi Liao, and Director Zhiping Zhang spoke highly of the design rationale and matching instrumentation of Takin™ Spinal Posterior Fixation System, especially for the cortex and cancellous bone thread design of pedicle screws in Takin™ Spinal Posterior Fixation System which shortens the surgery time and improves surgical efficiency.

Takin™ Spinal Posterior Fixation System was launched in 2015. The successful result of the surgery treating complex spinal tumor demonstrated the clinical value and market recognition of Takin™ Spinal Posterior Fixation System, and meanwhile creates a good beginning for the popularization of Takin™ Spinal Posterior Fixation System in the spinal orthopedic field and paves the way for MicroPort Orthopedics' spine and trauma team to increase its awareness in China.

About MicroPort

MicroPort Scientific Corporation (the 'Group') is a leading medical device company with business focusing on innovating, manufacturing, and marketing high-quality and high-end medical devices globally. With a diverse portfolio of products now being used at an average rate of one for every 15 seconds in thousands of major hospitals around the world, the Group maintains world-wide operations in a broad range of business segments including Cardiovascular, Orthopedic, Electrophysiological, Endovascular, Neurovascular, Surgical, Diabetes Care and Endocrinal Management, and others. MicroPort is dedicated to becoming a patient oriented global enterprise improve and reshape patient lives through application of innovative science and technology.

For more information, please refer to: www.microport.com

Forward-Looking Statements

Some information contained on this website contains forward-looking statements. These forward-looking statements include, without limitation, those regarding our future financial position, our strategy, plans, objectives, goals and targets, future developments in the markets where we participate or are seeking to participate, and any statements preceded by, followed by or that include the words 'believe', 'intend', 'expect', anticipate', 'project', 'estimate', 'predict', 'is confident', 'has confidence' and similar expressions are also intended to identify forward-looking statements. Such statements are based upon the current beliefs and expectations of MicroPort's management and are subject to significant risks and uncertainties. MicroPort Scientific Corporation undertakes no obligation to update any of the statements. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and other factors that could cause actual future results to differ materially from current expectations include, but are not limited to, general industry and economic conditions, PRC governmental policies and regulations relating to the medical device manufacturing industry, competition in the medical device manufacturing industry, our ability to develop new products and stay abreast of market trends and technological advances, our goals and strategies, our ability to execute strategic acquisitions of, investments in or alliances with other companies and businesses, fluctuations in general economic and business conditions in China.

This document is for information purposes only and does not constitute or form part of any offer or invitation to sell or the solicitation of an offer or invitation to purchase or subscribe for any securities of MicroPort Scientific Corporation, and no part of it shall form the basis of, or be relied upon in connection with, any agreement, arrangement, contract, commitment or investment decision in relation thereto whatsoever.

All rights reserved.
Copyright © 2017 MicroPort Scientific Corporation